A novel 1,2,4-triazole derivative inhibits epithelial-mesenchymal transition in metastatic colorectal cancer via β-catenin suppression
- 21 October 2025
- journal article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 302 (Pt 1) , 118279
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Wnt/β-catenin-driven EMT regulation in human cancersCellular and Molecular Life Sciences, 2024
- Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transitionClinical & Experimental Metastasis, 2023
- Apoptotic Bodies: Mechanism of Formation, Isolation and Functional Relevance2021
- Role of p38γ MAPK in regulation of EMT and cancer stem cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine‐Type Schiff Base Derivatives as Tubulin Polymerization InhibitorChemistry & Biodiversity, 2018
- Epithelial to mesenchymal transition correlates with tumor budding and predicts prognosis in esophageal squamous cell carcinomaJournal of Surgical Oncology, 2014
- A method for in silico identification of SNAIL/SLUG DNA binding potentials to the E-box sequence using molecular dynamics and evolutionary conserved amino acidsJournal of Molecular Modeling, 2013
- MicroRNA control of epithelial–mesenchymal transition and metastasisCancer and Metastasis Reviews, 2012
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009